Literature DB >> 21498730

The evaluation of MSX2 mRNA expression level in biliary brush cytological specimens.

Hiromichi Ito1, Kennichi Satoh, Shin Hamada, Morihisa Hirota, Atsushi Kanno, Kazuyuki Ishida, Jun Unno, Atsushi Masamune, Yu Katayose, Michiaki Unno, Tooru Shimosegawa.   

Abstract

BACKGROUND: To distinguish cholangiocarcinoma from inflammatory disease remains difficult when stricture is present in the bile duct. Endoscopic brushing cytology is a convenient method for stricture in the bile duct, however, the diagnostic sensitivity of this method for malignancy is reported to be low (<60%). Msh homeobox 2 is frequently expressed in carcinoma cells of epithelial origin but not in normal tissues. AIM: To assess whether MSX2 expression level in brushing samples allows differentiation of malignant from benign bile duct stricture. PATIENTS AND METHODS: Cytological brushing specimens were obtained from strictures of the bile duct during endoscopic retrograde cholangiopancreaticography (ERCP) in 71 patients. The brushing fluid was subjected to cytological diagnosis and RNA extraction. The expression level of MSX2 was evaluated by one-step real-time RT-PCR.
RESULTS: MSX2 expression levels were significantly higher in malignant than in benign bile duct stricture (p=0.004). The sensitivity and specificity for cholangiocarcinoma of cytology and MSX2 expression in strictures of the bile duct were: 55.3% and 100%, and 72.3% and 58.3%, respectively.
CONCLUSION: The sensitivity of MSX2 expression level for cholangiocarcinoma was much higher than that of cytology. This suggests that the evaluation of MSX2 level in ERCP brushing samples would be a useful tool to distinguish malignant from benign bile duct stricture.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21498730

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma.

Authors:  Michael H Chapman; Robert Tidswell; James S Dooley; Neomal S Sandanayake; Virginie Cerec; Maesha Deheragoda; Alvin J X Lee; Charles Swanton; Fausto Andreola; Stephen P Pereira
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

2.  MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinoma.

Authors:  Kennichi Satoh; Shin Hamada; Tooru Shimosegawa
Journal:  Front Physiol       Date:  2012-11-14       Impact factor: 4.566

3.  Diagnosis of bile duct cancer by bile cytology: usefulness of post-brushing biliary lavage fluid.

Authors:  Shinya Sugimoto; Hiroyuki Matsubayashi; Hirokazu Kimura; Keiko Sasaki; Kaori Nagata; Sachiyo Ohno; Katsuhiko Uesaka; Keita Mori; Kenichiro Imai; Kinichi Hotta; Kohei Takizawa; Naomi Kakushima; Masaki Tanaka; Noboru Kawata; Hiroyuki Ono
Journal:  Endosc Int Open       Date:  2015-05-07

4.  mRNA expression of CDH3, IGF2BP3, and BIRC5 in biliary brush cytology specimens is a useful adjunctive tool of cytology for the diagnosis of malignant biliary stricture.

Authors:  Tae Ho Kim; Jae Hyuck Chang; Hee Jin Lee; Jean A Kim; Yeon Soo Lim; Chang Whan Kim; Sok Won Han
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.